Michael Sela

Michael Sela (Hebrew: מיכאל סלע; Mieczysław Salomonowicz; 2 March 1924 – 27 May 2022) was a Polish-born Israeli immunologist. He was the W. Garfield Weston Professor of Immunology at the Weizmann Institute of Science in Rehovot.[1] He was the president of the Weizmann Institute of Science from 1975 until 1985.[2] He was probably best known as the co-developer (with Ruth Arnon and Dvora Teitelbaum) of the multiple sclerosis drug copaxone.

Michael Sela
מיכאל סלע
Michael Sela
Born
Mieczysław Salomonowicz

(1924-03-02)2 March 1924
Tomaszów Mazowiecki, Poland
Died27 May 2022 (aged 98)
NationalityIsraeli
Occupationimmunologist
Known for
TitleW. Garfield Weston Professor of Immunology at the Weizmann Institute of Science
Awards
  • The Israel Prize in Life Sciences (1959)
  • Germany's Otto Warburg Medal (1968)
  • The Rothschild Prize (1968)
  • Canada's Gairdner Foundation International Award (1980)
  • Germany's Commander's Cross of the Order of Merit Award (1986)
  • France's Officier de l'Ordre de la Légion d'honneur (1987)
  • Interbrew-Baillet Latour Health Prize of Belgium (1997)
  • The Wolf Prize in Medicine (1998)

Sela died on 27 May 2022 at the age of 98.[3]

References
  1. Michael Sela at the Weizmann Institute of Science
  2. "Prof. Michael Sela | Still hard at work, pursuing the understanding of immunology | WeizmannCompass". Weizmann.ac.il. 2017-06-04. Retrieved 2020-02-10.
  3. "מסע הקסם המדעי - חדשות מדע, תגליות ומידע לציבור מבית מכון ויצמן למדע". מסע הקסם המדעי - חדשות מדע, תגליות ומידע לציבור מבית מכון ויצמן למדע (in Hebrew). Retrieved 2022-05-28.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.